In the spleen, the abundance of myeloid cells (CD11b+ cells) was significantly lower relative to peripheral blood in both healthy and tumor-bearing mice (around 1% for M-MDSCs and up to 5% for PMN-MDSCs), and tumor development did not markedly alter this parameter (Figure 2B). Here, ITGAM is linked to neoplasm.